Your partner in cell transplantation needs...
Merisis Therapeutics is a fully owned division of DiponEd.
Merisis is positioned to be a technology support provider to clinicians and hospitals for all their cell, stem cell and biomaterial transplantation needs. Merisis also offeres development and marketing of Natural remedies and also somatic cell, immune cells, and stemcell therapies while combining them with the latest of 3rd generation Nano -Biomaterials. Development of Bioartificial tissues/ organs and Drug screening platforms are two other areas of research and development.
Merisis therapeutics - through its starategic partners and doctors/ surgeons offer - consultancies on different stem cell and biomaterials based therapies, covering a range of over 80 difficult to treat or no option diseases or unmet medical conditions eg., DMD, cancer, HIV, cosmetic corrections, breast agumentation, baldness, diabetes, wounds, cardiovascular diseases CAD/ PAD, neuro- degenerative diseases Parkinsons, MND, MS, autoimmune diseases IgA nephropathy, diabetes, Artheritis, spinal cord injuries, ligament and muscle injuries etc. It also promotes natural products that enhance systemic stem cells and stem cell based regeneration.
Merisis has started its Immunotherapy progrem with Prof Dr Appa Rao
Treatment Covers-- Chronic allergy, Pain, Inflamation, Autoimmune diseases, Cancer etc.
QUICK INFORMATION DOWNLOADS:
A list of our proprietory technologies, ready for outlicensing or commercializing JV, is available on request. Please mail us your queries at: email@example.com